Asbestos Cancer Lawsuits | Asbestos cancer lawsuits news

... Welcome to RCRNews.com LoginSign InRegister TodayGet customemail alertsSubscribeReceive fullonline accessRSSReal time updatesClassifiedView or place adsData from RCR Wireless News- Please Select -U.S.

Wireless Carrier DatabaseInternational Mobile Carrier DatabaseDirectory of U.S.

CarriersWorldwide Carrier Chart Breaking NewsE-mail StoryPrint StoryResearch firm forecasts trouble for industry following court decision By Jeffrey Silva Nov 3, 2005WASHINGTON-A leading telecom research firm said the Supreme Court's decision to allow mobile phone radiation lawsuits to move forward in state courts could mean trouble for wireless manufacturers and service providers.

"The Supreme Court's recent ruling confirms Precursor's belief that the Pandora's Box of joint and severable liability for health effects of cellphone radiation could plague cellphone manufacturers-especially Nokia [Corp.], [L.M.] Ericsson, Motorola [Inc.], Samsung [Electronics Co.

Ltd.]-and possibly less so [for] service providers-especially Cingular [Wireless L.L.C.], Sprint [Nextel Corp.], T-Mobile [USA Inc.] and Verizon [Wireless]-with repeated cycles of protracted tobacco- and asbestos-style litigation that takes years to resolve, generating headline risk, even though the financial impact of limited damage awards is unlikely to be severe," stated Rudy Baca in a Nov.

2 Precursor Bulletin obtained by RCR Wireless News.continued below Baca, predicting at l...

... Madison County Record www.stclairrecord.com Metro East's Legal Journal SUBSCRIBE To get our free email newsletter and make changes to your subscription: enter email address Subscribe to Print Edition SEARCH Search for: RSS FEED Stay up-to-date on all our content using your RSS reader.

Simply click the links below.

NEWS Dicta Features Federal Court Madison County New Lawsuits St.

Clair County Ill.

Appellate Court Ill.

Supreme Court Q & A NEWS ARCHIVE THE DOCKET Friday, Nov.

4 Thursday, Nov.

3 Tuesday, Nov.

1 Monday, Oct.

31 Wednesday, Oct.

26 THE DOCKET ARCHIVE ARGUMENTS Cartoons Letters to the Editor Our View Their View ARGUMENTS ARCHIVE PHOTOS Sandra's Alterations Celebrating a Ribbon Cutting with the O'Fallon Chamber - 10/24/2005Cut-a-thon at A Signature Hollywood Salon - 10/24/2005Bras R Us - 10/20/2005PHOTOS ARCHIVES ASBESTOS DOCKET Asbestos Motion Docket: Monday, Oct.

31 Asbestos Jury Docket: Monday, Oct.

31 ASBESTOS DOCKET ARCHIVE ABOUT US Legal Notices for Publication Place a Classified ad Where can you find the print edition of The Record ?

Contact The Record By way of introduction ADVERTISING You can advertise in The Record!

UPCOMING EVENTS FREE HEALTH AND W...

... Mesothelioma Treatment 101 Web juiceenewsdaily.com Advertise on Juicee News Mesothelioma Treatment 101(JND) - Treatment of MM using conventional therapies has not proved successful and patients have a median survival time of 6 - 12 months after presentation.

The clinical behaviour of the malignancy is affected by several factors including the continuous mesothelial surface of the pleural cavity which favours local metastasis via exfoliated cells, invasion to underlying tissue and other organs within the pleural cavity, and the extremely long latency period between asbestos exposure and development of the disease.

Surgery: Surgery, either by itself or used in combination with pre- and post-operative adjuvant therapies has proved disappointing with a 5 year survival rate of less than 10%.

Radiation: Although the tumour is highly resistant to radiotherapy and chemotherapy, these regimens are sometimes used to relieve symptoms arising from tumour metastases such as obstruction of a major blood vessel.

Chemotherapy: In February 2004, the Food and Drug Administration approved pemetrexed (brand name Alimta) for treatment of malignant pleural mesothelioma.

Immunotherapy: Treatment regimens involving immunotherapy have yielded variable results.

For example, intrapleural inoculation of Bacillus Calmette-Guérin (BCG) in an attempt to boost the immune response, was found to be of no benefit to the patient (while it may benefit patients with bladder cancer).

Mesothelioma cells proved sus...